BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 27187546)

  • 1. Importance and usage of the CHA2DS2-VASc score in predicting acute stent thrombosis.
    Ünal S; Açar B; Yayla Ç; Balci MM; Ertem A; Kara M; Maden O; Dereağzi ŞF
    Coron Artery Dis; 2016 Sep; 27(6):478-82. PubMed ID: 27187546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CHA2DS2-VASc Score is a Predictor of No-Reflow in Patients With ST-Segment Elevation Myocardial Infarction Who Underwent Primary Percutaneous Intervention.
    Ipek G; Onuk T; Karatas MB; Gungor B; Osken A; Keskin M; Oz A; Tanik O; Hayiroglu MI; Yaka HY; Ozturk R; Bolca O
    Angiology; 2016 Oct; 67(9):840-5. PubMed ID: 26685178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CHADS2 and CHA2DS2-VASc scores as predictors of left atrial ablation outcomes for paroxysmal atrial fibrillation.
    Letsas KP; Efremidis M; Giannopoulos G; Deftereos S; Lioni L; Korantzopoulos P; Vlachos K; Xydonas S; Kossyvakis C; Sideris A
    Europace; 2014 Feb; 16(2):202-7. PubMed ID: 23813452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the Predictive Value of CHA
    Yilmaz S; Akboga MK; Aras D; Topaloglu S
    Angiology; 2018 Jan; 69(1):38-42. PubMed ID: 28345395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-stroke CHADS2 and CHA2DS2-VASc scores are useful in stratifying three-month outcomes in patients with and without atrial fibrillation.
    Tu HT; Campbell BC; Meretoja A; Churilov L; Lees KR; Donnan GA; Davis SM
    Cerebrovasc Dis; 2013; 36(4):273-80. PubMed ID: 24135809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of CHA2DS2-VASc Score for Prediction and Ruling Out of Acute Stent Thrombosis After Primary Percutaneous Coronary Intervention.
    Açikgöz SK; Açikgöz E; Çiçek G
    Angiology; 2020 May; 71(5):411-416. PubMed ID: 32030991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CHADS2, CHA2DS2-VASc and HAS-BLED as predictors of outcome in patients with atrial fibrillation undergoing percutaneous coronary intervention.
    Puurunen MK; Kiviniemi T; Schlitt A; Rubboli A; Dietrich B; Karjalainen P; Nyman K; Niemelä M; Lip GY; Airaksinen KE
    Thromb Res; 2014 Apr; 133(4):560-6. PubMed ID: 24461143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlates and outcomes of late and very late drug-eluting stent thrombosis: results from DESERT (International Drug-Eluting Stent Event Registry of Thrombosis).
    Waksman R; Kirtane AJ; Torguson R; Cohen DJ; Ryan T; Räber L; Applegate R; Waxman S; Gordon P; Kaneshige K; Leon MB;
    JACC Cardiovasc Interv; 2014 Oct; 7(10):1093-102. PubMed ID: 25240540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of the CHA2DS2-VASC Score to Predict Adverse Outcomes in Patients Having Percutaneous Coronary Intervention.
    Orvin K; Bental T; Assali A; Lev EI; Vaknin-Assa H; Kornowski R
    Am J Cardiol; 2016 May; 117(9):1433-8. PubMed ID: 27001448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CHA
    Zhao SG; Xu JJ; Tao ZH; Jin L; Liu Q; Zheng WY; Jiang LQ; Wang NF
    J Int Med Res; 2019 Jun; 47(6):2533-2544. PubMed ID: 31039653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SYNTAX score and the risk of stent thrombosis after percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes: an ACUITY trial substudy.
    Yadav M; Généreux P; Palmerini T; Caixeta A; Madhavan MV; Xu K; Brener SJ; Mehran R; Stone GW
    Catheter Cardiovasc Interv; 2015 Jan; 85(1):1-10. PubMed ID: 24408084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New CHA
    Zhang QY; Ma SM; Sun JY
    BMC Cardiovasc Disord; 2020 Jul; 20(1):346. PubMed ID: 32711475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive value of CHADS
    Li X; Zeng Z; Yang X; Wang H
    BMC Cardiovasc Disord; 2021 Sep; 21(1):439. PubMed ID: 34525958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of the CHA2DS2-VASc Score in Predicting In-Stent Restenosis Among Patients Undergoing Revascularization With Bare-Metal Stents.
    Kurtul A
    Clin Appl Thromb Hemost; 2018 May; 24(4):589-595. PubMed ID: 28675046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The anatomic- and clinical-based NERS (new risk stratification) score II to predict clinical outcomes after stenting unprotected left main coronary artery disease: results from a multicenter, prospective, registry study.
    Chen SL; Han YL; Zhang YJ; Ye F; Liu HW; Zhang JJ; Xu B; Jiang TM; Zhou YJ; Lv SZ
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1233-41. PubMed ID: 24239199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive Value of CHA2DS2-VASC Score for Contrast-Induced Nephropathy After Percutaneous Coronary Intervention for Acute Coronary Syndrome.
    Kurtul A; Yarlioglues M; Duran M
    Am J Cardiol; 2017 Mar; 119(6):819-825. PubMed ID: 28040187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical utility of CHADS2 and CHA2DS2-VASc scoring systems for predicting postoperative atrial fibrillation after cardiac surgery.
    Chua SK; Shyu KG; Lu MJ; Lien LM; Lin CH; Chao HH; Lo HM
    J Thorac Cardiovasc Surg; 2013 Oct; 146(4):919-926.e1. PubMed ID: 23628495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of the CHA
    Peng H; Sun Z; Chen H; Zhang Y; Ding X; Zhao XQ; Li H
    Am J Cardiol; 2019 Aug; 124(4):476-484. PubMed ID: 31235063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved safety and reduction in stent thrombosis associated with biodegradable polymer-based biolimus-eluting stents versus durable polymer-based sirolimus-eluting stents in patients with coronary artery disease: final 5-year report of the LEADERS (Limus Eluted From A Durable Versus ERodable Stent Coating) randomized, noninferiority trial.
    Serruys PW; Farooq V; Kalesan B; de Vries T; Buszman P; Linke A; Ischinger T; Klauss V; Eberli F; Wijns W; Morice MC; Di Mario C; Corti R; Antoni D; Sohn HY; Eerdmans P; Rademaker-Havinga T; van Es GA; Meier B; Jüni P; Windecker S
    JACC Cardiovasc Interv; 2013 Aug; 6(8):777-89. PubMed ID: 23968698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of stent thrombosis among bare-metal stents, first-generation drug-eluting stents, and second-generation drug-eluting stents: results from a registry of 18,334 patients.
    Tada T; Byrne RA; Simunovic I; King LA; Cassese S; Joner M; Fusaro M; Schneider S; Schulz S; Ibrahim T; Ott I; Massberg S; Laugwitz KL; Kastrati A
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1267-74. PubMed ID: 24355117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.